Article
Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Diabetologia - 1 Sept 2021
Gu Yong, Jia Xiaofan, Vartak Tanwi, Miao Dongmei, Dong Fran, Jerram Samuel T, Rewers Marian, Ferrara Assiamira, Lawrence Jean M, Yu Liping, Leslie R David
Abstract excerpt
AIMS/HYPOTHESIS: It is important to differentiate the two major phenotypes of adult-onset diabetes, autoimmune type 1 diabetes and non-autoimmune type 2 diabetes, especially as type 1 diabetes presents in adulthood. Serum GAD65 autoantibodies (GADA) are the most sensitive biomarker for adult-onset autoimmune type 1 diabetes, but the clinical value of GADA by current standard radiobinding assays (RBA) remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
